Showing results (371-380 of 881) with videos related to
Sort By:
Pageof 89
Clinical and Experimental Rheumatology|September 1, 1995
Asymptomatic pericarditis in Adamantiadis-Behçet's diseaseG Vaiopoulos, G Stamatelos, A Aessopos, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 17, 2016
Targeting collagen for diagnostic imaging and therapeutic deliveryHendra Wahyudi, Amanda A Reynolds, Yang Li, et al.Journal of Global Antimicrobial Resistance|October 27, 2019
Candida auris: Clinical profile, diagnostic challenge and susceptibility pattern: Experience from a tertiary-care centre in South IndiaMarilyn M Ninan, Rani D Sahni, Binila Chacko, et al.Journal of Synchrotron Radiation|February 24, 2007
Diffraction-based automated crystal centeringJinhu Song, Deepa Mathew, Sandhya A Jacob, et al.Mabs|December 9, 2014
First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteersMisty W Stevens, Ralph L Henry, S Michael Owens, et al.Tropical Medicine & International Health : TM & IH|December 17, 2015
Xpert MTB/Rif for the diagnosis of extrapulmonary tuberculosis--an experience from a tertiary care centre in South IndiaShirly Suzana, Marilyn M Ninan, Mahasampath Gowri, et al.Stroke|November 19, 2016
Door-to-Imaging Time for Acute Stroke Patients Is Adversely Affected by Emergency Department CrowdingMartin A Reznek, Evangelia Murray, Marguerite N Youngren, et al.Applied Spectroscopy|October 6, 2023
Single-Grating Monolithic Spatial Heterodyne Raman Spectrometer: An Investigation on the Effects of Detector SelectionEvan M Kelly, Miles J Egan, Arelis Colόn, et al.Vaccine|September 25, 2014
Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month periodMichael D Hambuchen, Daniela Rüedi-Bettschen, D Keith Williams, et al.Human Vaccines & Immunotherapeutics|May 11, 2016
Chronic treatment of (+)-methamphetamine-induced locomotor effects in rats using one or a combination of two high affinity anti-methamphetamine monoclonal antibodiesMichael D Hambuchen, Daniela Rüedi-Bettschen, Melinda G Gunnell, et al.Pageof 89